IONIS PHARMACEUTICALS INC earnings per share and revenue

ISI earnings per share for the last quarter are -0.88 CHF whereas the estimation was -0.93 CHF which accounts for 5.12% surprise. Företagets omsättning för samma period uppgår till 107.35 M CHF trots den uppskattade siffran 118.56 M CHF. Estimated earnings per share for the next quarter are -0.87 CHF, and revenue is expected to reach 133.91 M CHF. Also watch annual changes over time to get a bigger picture of ISI earnings per share and revenue dynamics.